Skip to content

Gross margin at other companies

Baxter International logo
Baxter InternationalBAX
30.1%-5.9pp
PTH
Pelthos Therapeutics Inc.PTHS
79.6%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
93.4%+3.7pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp
RFL
Rafael Holdings, Inc.RFL
71.9%
Opko Health logo
Opko HealthOPK
36%+4.2pp

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+142%
Enterprise value$90.91M+212%
P/S2.3×+1.4×

Profitability

See full
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Calculated from Cumberland Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's gross margin?
Cumberland Pharmaceuticals (CPIX) reported gross margin of 82.9% in Q1 2026.
How has Cumberland Pharmaceuticals's gross margin changed year-over-year?
Cumberland Pharmaceuticals's gross margin decreased by 1.7% year-over-year, from 84.3% to 82.9%.
What is the long-term trend for Cumberland Pharmaceuticals's gross margin?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's gross margin has grown at a 2.0% compound annual growth rate (CAGR), from 76.9% to 85%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.